Marketing problems of your products

As for the global launch new products, to get as much as possible market share in the shortest time, more resource are allocated, it is expected to be detailed to many specialties with as high as possible call frequency.

As for the matured products, it is important to maintain focused noise to selected segments and screening out new segments to penetrate.

Companies spend a lot on the promotion of new treatment guideline, it is important to track if and in what extend the therapy regimens are adopted.

The key issue is to take a close track for the doctors' prescription on specific indication, with comfortable control on its sampling error and measurement error.

There is a high incidence of hypertension in China which presents a real threat to the healthof the population. At present, most of the top pharmaceutical companies have cardiovascular products, especially anti-hypertensives.

Do you know the "end users" of your products, and who

prescribes them?

Do you target the right segment for your product?

What are the potential segments for your product?

How are new competitors doing? Who are the prescribers of

these competitive products and for which group of patients?

What are the prescription trends of your products: is there

more combination therapy being prescribed, or is there a

change in dosage levels?

In order to meet client needs, Shanghai Loudon Marketing Consultant Co. has developed a syndicated study - Prescription Tracking which offers our clients a tool to monitor the market status of their anti-hypertensives.

Objectives

The main objectives of the study are to:

Segment hypertensive market by patients' profile (hypertension

types; concomitant conditions), and treatment pattern

(mono/combination, users of specific catergory anti-

hypertensive, etc.)

Track prescription pattern of doctors (hypertension types;

concomitant conditions; hospital level, beds, professional title)

and acceptance for new regimens

Define market opportunities by entering into new segments,

fine tune the usage of products

Bench marketing, establish competitive edges against

competitors

Analysis the trends of prescription pattern by category or

product

Methodology

In Wave2005, total 3,300 patients will be recorded in 5 departments of 8 cities. The sample is as follows

6 categories of cardiovascular medicines have been analyzed including:

-

Calcium antagonists

-

Diuretics

-

AIIA/ARB

-

ACE-I

-

Compounds (including TCMs, etc.)

-

Beta blockers

Detailed patient information has been recorded covering:

-

Patients demographics, including age, gender, weight and

height, health care insurance status, department consulted,

BP (SBP, DBP), concomitant conditions, etc.

-

Medicine prescribed, manufacturers, presentations,

strength, dose, combination or mono therapy

Key findings of the reports

Size and profile of patient segments

-

By hypertension type

-

By concomitant condition

-

By blood pressure level

-

By healthcare insurance status

-

By city

Prescription of categories and products

By patient segments

-

By doctor segment: department/professional

position/hospital level

Doctors' prescription pattern for each patient segments

-

By mono/combination therapy

-

By category/product

-

By physicians department

Application

As a tracking report, it will identify details of patients demographics, analyse the competitive environment, help to develop competitive positioning strategies for the products, and track the effectiveness of marketing activities for the launch of new products or indications. Following information can be get from the report:

Market size / patient number of each segment of hypertension

Patient profile of each segment of hypertension

Define the market attractiveness and potential of the product in

each segment

Therapy and prescription analysis of each segment

Usage and prescription pattern of hypertension in each

segment

If you have additional specific questions about your product we are able to provide tailor made analysis with our methods and the large database available to us.